Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]

Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

[No abstract available]

키워드

Amfebutamone; Amine Oxidase (flavin Containing); C Reactive Protein; Insulin; Naltrexone; Amfebutamone Plus Naltrexone; Amfebutamone; Amine Oxidase (flavin Containing); C Reactive Protein; High Density Lipoprotein Cholesterol; Insulin; Low Density Lipoprotein Cholesterol; Monoamine; Naltrexone; Triacylglycerol; Amfebutamone Plus Naltrexone; Blood Pressure; Cardiovascular Risk; Clinical Trial (topic); Heart Rate; Human; Letter; Lipid Blood Level; Medical Practice; Mental Disease; Obesity; Phase 3 Clinical Trial (topic); Quality Of Life; Waist Circumference; Drug Therapy; Note; THERAPY; WEIGHT
제목
Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]
저자
Lyu, Young Sang; Ahn, Hongyup; Hong, Sangmo; Park, Cheol-Young
DOI
10.2147/DDDT.S512114
발행일
2025
유형
Letter
저널명
Drug Design, Development and Therapy
권
19
페이지
65 ~ 66